Rizvi Syed Ali-aamir
SEC insider (Form 3/4/5 filer). CIK 0001897621. Chief Medical Officer at ROCKET PHARMACEUTICALS, INC. (RCKT) and 1 other issuer. 5 reported Form 4/5 transactions since Sep 2024; latest on Feb 11, 2026. Located in CRANBURY, NJ.
Companies Rizvi Syed Ali-aamir has filed insider reports for
- ROCKET PHARMACEUTICALS, INC. (RCKT): Officer, Chief Medical Officer
- Poseida Therapeutics, Inc. (PSTX): Officer, Chief Medical Officer
Rizvi Syed Ali-aamir
CIK: 0001897621
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Feb 11, 2026RCKT
ROCKET PHARMACEUTICALS, INC.
AwardDirect62K shares- - Oct 6, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
AwardDirect283K shares- - Oct 6, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
AwardDirect62.9K shares- - Jan 8, 2025PSTX
Poseida Therapeutics, Inc.
Tender OfferDirect185K shares- - Jan 8, 2025PSTX
Poseida Therapeutics, Inc.
DispositionDirectEmployee Stock Option (Right to Buy)
250K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 11, 2026 |  RCKT ROCKET PHARMACEUTICALS, INC. | Award | 61,963 | - | $0 | Direct |
| Oct 6, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | Award | 283,018 | - | - | Direct |
| Oct 6, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | Award | 62,893 | - | - | Direct |
| Jan 8, 2025 |  PSTX Poseida Therapeutics, Inc. | Tender Offer | 185,000 | - | $0 | Direct |
| Jan 8, 2025 | PSTX Poseida Therapeutics, Inc. | Disposition Employee Stock Option (Right to Buy) | 250,000 | - | - | Direct |
1-5 of 5 transactions